Refine by
Neurodegeneration Equipment Supplied In Canada
6 equipment items found
Manufactured by:eNUVIO inc. based inMontreal, QUEBEC (CANADA)
Get more out of your neuronal cultures and co-cultures with the latest in microfluidic devices from eNUVIO. OMEGA4 devices can be used for in vitro co-culture studies of neurodegeneration, neuromuscular junction (NMJ), nigrostriatal pathway, pain, myelination, or chemotactic factors. In single culture applications, the OMEGA4 can serve as a compartmentalization tool to separate ...
Manufactured by:eNUVIO inc. based inMontreal, QUEBEC (CANADA)
Get even more out of your neuronal cultures and co-cultures with the latest in microfluidic devices from eNUVIO. OMEGAACE devices can be used for in vitro triple co-culture studies of neurodegeneration, neuromuscular junction (NMJ), nigrostriatal pathway, pain, myelination, or chemotactic factors. In single culture applications, the OMEGAACE can also serve as a ...
Manufactured by:eNUVIO inc. based inMontreal, QUEBEC (CANADA)
Each experimental unit consists of one standard sized chamber and one small chamber. OMEGA4-2mini devices can be used for in vitro co-culture studies of neurodegeneration, neuromuscular junction (NMJ), nigrostriatal pathway, pain, myelination, or chemotactic factors. In single culture applications, the OMEGA4-2mini can serve as a compartmentalization tool to separate the somatic ...
Manufactured by:eNUVIO inc. based inMontreal, QUEBEC (CANADA)
Each experimental unit consists of one standard sized chamber and one small chamber. OMEGA4-2mini-2mm devices can be used for in vitro co-culture studies of neurodegeneration, neuromuscular junction (NMJ), nigrostriatal pathway, pain, myelination, or chemotactic factors. In single culture applications, the OMEGA4-2mini-2mm can serve as a compartmentalization tool to separate the ...
Manufactured by:Renishaw plc based inGloucestershire, UNITED KINGDOM
Novel chronic and acute catheter systems for direct delivery of therapeutics to the ...
Manufactured by:BlueRock Therapeutics based inCambridge, MASSACHUSETTS (USA)
With our cell+gene platform, BlueRock is aiming to redefine the very way we treat disease, moving from addressing mere symptoms to restoring health lost to cell damage or degeneration. Instead of prescribing a pill to treat tremors in patients with Parkinson’s, we might restore the chemical messengers that were destroyed, addressing tremors at the source. Those who have suffered a heart ...